Hydrogen Research Study
← Back to Research Library
Preclinical animal evidenceAnimal studyOther or not reported

Protective effects of hydrogen-rich saline on monocrotaline-induced pulmonary hypertension in a rat model.

Yun Wang, Lei Jing, Xiao-Min Zhao, Ji-Ju Han, Zuo-Li Xia, Shu-Cun Qin, Ya-Ping Wu, Xue-Jun Sun · Respiratory research · 2011

Research-use notice

Independent study record

Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.

H2HUBB Research Library branded molecular hydrogen research image
Primary topic Blood Pressure and Vascular Function
Evidence type Preclinical animal evidence
Publication type Animal study
Hydrogen method Other or not reported

H2HUBB TAKEAWAY

In male Sprague-Dawley rats, hydrogen-rich saline treatment improved hemodynamics and reversed right ventricular hypertrophy. These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.

What the Findings Mean

H2HUBB reviewed how molecular hydrogen affected the outcomes measured in male Sprague-Dawley rats. Hydrogen-rich saline treatment improved hemodynamics and reversed right ventricular hypertrophy.

What the Researchers Studied

The researchers studied male Sprague-Dawley rats. The study used a preclinical animal experiment.

What Effects Did Molecular Hydrogen Have?

Hydrogen-rich saline (5 ml/kg) or saline was administered intraperitoneally once daily for 2 or 3 weeks. Hydrogen-rich saline treatment improved hemodynamics and reversed right ventricular hypertrophy. The authors concluded that these results suggest that hydrogen-rich saline ameliorates the progression of pulmonary hypertension induced by monocrotaline in rats, which may be associated with its antioxidant and anti-inflammatory effects. Hydrogen-rich saline has been reported to have antioxidant and anti-inflammatory effects and effectively protect against organ damage.

Why These Findings Matter

These preclinical findings add evidence supporting molecular hydrogen's therapeutic potential within the outcomes and biological pathways measured in this model.

How Strong Is This Evidence?

This is preclinical animal evidence from a preclinical animal experiment. It is most informative for the disease model, mechanisms, biomarkers, and outcomes directly measured in the study.

Technical Study Details

H2HUBB classifies this publication as animal study with preclinical animal evidence. The research population or model was male Sprague-Dawley rats. The study used a preclinical animal experiment.

Limitations and Safety

No separate limitations or safety findings were identified in the source text available to H2HUBB.

Original Study and H2HUBB Research Context

H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.